抑制自身免疫CD25KO小鼠中的组织蛋白酶S可改善干燥病样泪腺病理
研究将4周龄雌性CD25KO小鼠随机分为含组织蛋白酶S(CTSS)抑制剂R05461111(262.5 mg/kg饲料)饲料组或标准饲料组喂养4周,发现CTSS抑制剂组角膜敏感性和泪腺炎症评分改善,引流淋巴结CD4+细胞频率显著降低、CD8+细胞频率显著升高,泪腺和引流淋巴结Th1、Th17细胞显著减少,Ifng、Ciita、Casp8 mRNA降低,寿命延长30%,过继转移其CD4+ T细胞可改善受体的角膜敏感性和炎症评分。
要点
- CTSS抑制剂饲料组小鼠角膜敏感性和泪腺炎症评分优于标准饲料组。
- CTSS抑制剂组引流淋巴结CD4+细胞频率显著降低、CD8+细胞频率显著升高。
- CTSS抑制剂组泪腺和引流淋巴结Th1、Th17细胞显著减少,Ifng、Ciita、Casp8 mRNA降低,寿命延长30%。
核心结论
- 抑制CTSS可能成为眼和泪腺干燥病(SjD)治疗的潜在途径。
研究设计与样本
- 4周龄雌性CD25KO小鼠随机接受含CTSS抑制剂R05461111(262.5 mg/kg饲料)饲料或标准饲料喂养4周。
- 比较两组角膜敏感性、泪腺炎症评分、引流淋巴结和泪腺流式细胞术、泪腺定量PCR及寿命。
- 将两组脾脏CD4+ T细胞过继转移至RAG1KO雌性受体。
主要发现
- CTSS抑制剂组角膜敏感性更好,泪腺炎症评分改善。
- CTSS抑制剂组引流淋巴结CD4+免疫细胞频率显著降低、CD8+免疫细胞频率显著升高。
- CTSS抑制剂组泪腺和引流淋巴结中Th1和Th17细胞显著减少。
- CTSS抑制剂组泪腺Ifng、Ciita和Casp8 mRNA降低。
- 接受CTSS抑制剂的小鼠寿命延长30%;过继转移CTSS抑制剂处理CD4+ T细胞的受体角膜敏感性改善、炎症评分降低。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: CD25KO mice are a model of Sjögren disease (SjD) driven by autoreactive T cells. Cathepsin S (CTSS) is a protease crucial for major histocompatibility complex class II presentation that primes T cells. We investigated if a diet containing CTSS inhibitor would improve autoimmune signs in CD25KO mice. METHODS: Four-week female CD25KO mice were randomly chosen to receive chow containing a CTSS inhibitor (R05461111, 262.5 mg/kg chow) or standard chow for 4 weeks. Cornea sensitivity was measured. Inflammatory score was assessed in lacrimal gland (LG) histologic sections. Flow cytometry of LG and ocular draining lymph nodes (dLNs) investigated expression of Th1 and Th17 cells. Expression of inflammatory, T- and B-cell, and apoptotic markers in the LG were assessed with quantitative PCR. The life span of mice receiving CTSS inhibitor or standard chow was compared. CD4+ T cells from both groups were isolated from spleens and adoptively transferred into RAG1KO female recipients. RESULTS: Mice receiving CTSS inhibitor had better cornea sensitivity and improved LG inflammatory scores. There was a significant decrease in the frequency of CD4+ immune cells and a significant increase in the frequency of CD8+ immune cells in the dLNs of CTSS inhibitor mice. There was a significant decrease in Th1 and Th17 cells in CTSS inhibitor mice in both LGs and dLNs. Ifng, Ciita, and Casp8 mRNA in CTSS inhibitor mice decreased. Mice that received the CTSS inhibitor lived 30% longer. Adoptive transfer recipients with CTSS inhibitor-treated CD4+ T cells had improved cornea sensitivity and lower inflammation scores. CONCLUSIONS: Inhibiting CTSS could be a potential venue for the treatment of SjD in the eye and LG.
引用
- Scholand KK, Galletti J, Haap W, et al. Inhibition of Cathepsin S in Autoimmune CD25KO Mouse Improves Sjögren Disease-Like Lacrimal Gland Pathology. Invest Ophthalmol Vis Sci. 2024. PMID: 39017634. doi:10.1167/iovs.65.8.26
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。